Tag Archives: Health Care

Patients Suffering from Gaucher’s Disease Deserve Better

scientist-eyedropper

Gaucher Disease is one of the over 6,000 rare diseases that affect patients worldwide, representing a frontier of unmet medical need [NCATS, NIH]. The challenges for drug development generally—long and costly research and development timelines—are exacerbated by the inherently small patient populations affected by rare diseases. These patients can be difficult to identify and geographically dispersed and their clinical presentation can be quite disparate, complicating the design and recruitment for clinical trials used to determine Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The New Republic: We are Entering the Age of Alzheimer’s

alzheimers

The New Republic this week published a lengthy, powerful piece by Kent Russell on Alzheimer’s. Russell opens the piece by noting that we are approaching a public health crisis in Alzheimer’s and dementia: Alzheimer’s disease is practically unheard of in adults younger than 40, and very rare (one in 2,500) for those under 60. It affects 1 percent of 65-year-olds, 2 percent of 68-year-olds, 3 percent of 70-year-olds. After that, the odds start multiplying. The Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Fighting Ebola with Tobacco

Ebola

Years in the making, the Ebola virus has recently erupted into a full blown health crisis. As of this week, it has claimed the lives over a thousand people – mostly in Liberia, Sierra Leone, and Guinea. Ebola is one of the world’s most virulent diseases and treating it is complicated by the fact that it is highly contagious and deadly. The infection is transmitted by direct contact with the blood, body fluids and tissues Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

New study shows hepatitis C burden may ease in future

cells115x76

Anew study published in the Annals of Internal Medicine projects that the prevalence of hepatitis C will shrink in the coming decades thanks to new medicines and increased screening regimens. Currently, approximately one in 100 people are infected with the virus, and researchers expect that number to drop to about one in 1,500 people by 2036 if patients have timely and affordable treatment. “We were pleasantly surprised that in the next 22 years we could Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

New York Times Building

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the attention the cost has received to date, those attacking the drug are “looking at the costs of Sovaldi in the wrong way.” Sanger-Katz acknowledges that these one-time treatments can be a ‘shock to the system,’ but notes the value far outweighs the expense since it cures the disease in the majority of patients, preventing further costly treatments and care. Sanger-Katz Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,